Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis

被引:5
|
作者
Le Teuff, Gwenael [1 ]
Abrahamowicz, Michal [2 ,3 ]
Wynant, Willy [2 ,3 ]
Binquet, Christine [4 ,5 ]
Moreau, Thibault [6 ]
Quantin, Catherine [4 ,5 ,6 ,7 ]
机构
[1] Inst Gustave Roussy, Dept Biostat & Epidemiol, Paris, France
[2] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada
[4] INSERM, CIC 1432, F-21000 Dijon, France
[5] Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol, Clin Trials Unit, Dijon, France
[6] Ctr Hosp Univ Dijon, Dept Neurol, F-21079 Dijon, France
[7] Ctr Hosp Univ Dijon, Dept Biostat & Med Informat, F-21079 Dijon, France
基金
加拿大健康研究院;
关键词
Prognostic studies; Multiple sclerosis; Disability; Attack frequency; Time-varying covariates; Time-dependent effects; LONG-TERM DISABILITY; CORONARY-HEART-DISEASE; IMMORTAL TIME BIAS; NATURAL-HISTORY; MULTIVARIATE-ANALYSIS; PREDICTIVE FACTORS; SURVIVAL ANALYSES; LUPUS NEPHRITIS; CLINICAL-COURSE; LUNG-CANCER;
D O I
10.1016/j.jclinepi.2014.11.011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: To illustrate the advantages of updating time-varying measures of disease activity and flexible modeling in prognostic clinical studies using the example of the association between the frequency of past relapses and occurrence of ambulation-related disability in multiple sclerosis (MS). Study Design and Setting: Longitudinal population-based study of 288 patients from Burgundy, France, diagnosed with relapsing remitting MS in 1990-2003. The end point was a nonreversible moderate MS disability (European Database for Multiple Sclerosis score >= 3.0 derived from Extended Disability Status Scale). Alternative time-varying measures of attacks frequency included (I) conventional number of early MS attacks in the first 2 years after diagnosis; and two new measures, continuously updated during the follow-up; (2) cumulative number of past attacks; and (3) number of recent attacks, during the past 2 years. Multivariate analyses used Cox proportional hazards model and its flexible generalization, which accounted for time-dependent changes in the hazard ratios (HRs) for different attack frequency measures. Results: HRs for all measures decreased significantly with increasing follow-up time. The proposed updated number of recent attacks improved model's fit to data, relative to alternative measures of attack frequency, and was associated with a statistically significantly increased hazard of developing ambulation-related MS disability in the next 2 years during the entire follow-up period. Conclusion: Updated measures of recent disease activity, such as frequency of recent attacks and modeling of their time-dependent effects, may substantially improve prognosis of clinical outcomes, such as development of MS disability. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 50 条
  • [1] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    [J]. WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [2] The association between disease activity and disability progression in patients with relapsing-remitting multiple sclerosis
    Spelman, T.
    Geale, K.
    Anell, B.
    Hillert, J.
    Wong, S. L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 127 - 128
  • [3] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [4] Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
    Lavery, Amy M.
    Verhey, Leonard H.
    Waldman, Amy T.
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2014, 2014
  • [5] Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis
    Motl, Robert W.
    Dlugonski, Deirdre
    Pilutti, Lara
    Sandroff, Brian
    McAuley, Edward
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) : 123 - 127
  • [6] Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis
    Rudick, Richard A.
    Lee, Jar-Chi
    Cutter, Gary R.
    Miller, Deborah M.
    Bourdette, Dennis
    Weinstock-Guttman, Bianca
    Hyde, Robert
    Zhang, Hao
    You, Xiaojun
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (11) : 1329 - 1335
  • [7] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [8] Cognitive decline predicts disability progression in relapsing-remitting multiple sclerosis
    Vermersch, Patrick
    Leuse, Delphine
    Cabaret, Maryline
    Outteryck, Olivier
    de Seze, Jerome
    Dujardin, Kathy
    Zephir, Helene
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S266 - S266
  • [9] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
  • [10] Disability trajectories in relapsing-remitting multiple sclerosis
    Uher, T.
    Horakova, D.
    Havrdova, E. Kubala
    Izquierdo, G.
    Eichau, S.
    Patti, F.
    Prat, A. P.
    Girard, M.
    Duquette, P.
    Grammond, P.
    Onofrj, M.
    Lugaresi, A. L.
    Bergamaschi, R.
    Ozakbas, S.
    Grand'Maison, F.
    Hupperts, R.
    Sola, P.
    Ferraro, D.
    Sa, M. J.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 813 - 814